[Recommendations] The Political Leadership and International Collaboration Needed to Advance Antimicrobial Resistance (AMR) Countermeasures (December 19, 2022)
date : 1/26/2023
Tags: AMR
Health and Global Policy Institute (HGPI) released recommendations for the G7 Hiroshima Summit entitled, “The Political Leadership and International Collaboration Needed to Advance Antimicrobial Resistance (AMR) Countermeasures.”
[Summary]
Recommendation 1: Continue providing the political leadership needed to combat AMR.
Recommendation 2: Establish opportunities to examine AMR countermeasures at discussions that span multiple fields like the Joint Conference of Foreign Ministers and Health Ministers.
Antimicrobial resistance (AMR) has been continuously recognized as a public health threat of greatest concern both in Japan and abroad, and concentrated efforts from various related parties around the world have resulted in steady progress in measures to combat AMR. In recent years, the G7 has recognized that achieving comprehensive innovation in all areas of prevention, diagnosis, and treatment will be crucial for pandemic prevention, preparedness, and response (PPR).
As we enter the post-COVID-19 era, we must not overlook the role of antimicrobials as global public goods if we wish to continue enjoying peace, stability, and prosperity.
As discussions on international agreements regarding infectious diseases like the International Health Regulation (IHR) and the Pandemic Treaty continue to advance, it will be important to promote AMR countermeasures based on the concept of One Health, in which the health of humans, animals, and the environment are viewed as one. To this end, opportunities for discussions that cut across fields and advocate for that approach should be established at G7 Summits and other high-level meetings. Consideration of financial resource mobilization is also required. As the next G7 President in 2023, it will be crucial for Japan to fulfill its commitments to the international community based on the fact that infectious disease control cannot be fully implemented by countries acting alone and that each country’s interests are adjacent to those of the entire world.
For further details, please see the end of the PDF.
Recommendations for the G7 Hiroshima Summit
The Political Leadership and International Collaboration
Needed to Advance Antimicrobial Resistance (AMR) Countermeasures
Background
Antimicrobial resistance (AMR) has been continuously recognized as a public health threat of greatest concern both in Japan and abroad and concentrated efforts from various related parties around the world have resulted in steady progress in measures to combat AMR. In recent years, the G7 has recognized that achieving comprehensive innovation in all areas of diagnosis, treatment, and prevention will be crucial for pandemic prevention, preparedness, and response (PPR). That perspective is in line with that of the G7 Ise-Shima Summit held in 2016 (the last time Japan served as G7 President) as well as those of Japan’s Basic Policies for Economic and Fiscal Management and Reform every year since 2016. Aiming to utilize this momentum, Health and Global Policy Institute (HGPI) presents the following recommendations on promoting more comprehensive and effective measures for AMR control in preparation for the upcoming G7 Hiroshima Summit in 2023. HGPI has already generated various recommendations on AMR control, including those that focus on the utilization of pull incentives. To view our recommendations regarding this issue, please visit our website.
Recommendation 1: Continue providing the political leadership needed to combat AMR.
Every year since the 2016 G7 summit, the importance of taking action to combat AMR has been mentioned in statements from the Health Ministers’ Meetings; the Finance Ministers and Central Bank Governors Meetings; the Agriculture Ministers’ Meetings; the Climate, Energy and Environment Ministers’ Meetings; and even at Leaders’ Summits. In February 2022, British medical journal The Lancet reported that in 2019, an estimated 1.27 million deaths worldwide were directly caused by AMR. This was higher than the number of deaths from HIV/AIDS and malaria. The annual number of global deaths due to AMR infections is projected to increase to about 10 million people by 2050, mostly in Asia and Africa. AMR is also a growing problem for the three major infectious diseases (HIV/AIDS, tuberculosis, and malaria). If appropriate measures to combat AMR had been in place among G7 members in 2019, a total of 500,000 lives may have been saved. G7 members should stand at the forefront of the international community and continue providing political leadership to advance AMR countermeasures.
Recommendation 2: Establish opportunities to examine AMR countermeasures at discussions that span multiple fields like the Joint Conference of Foreign Ministers and Health Ministers.
Beyond the G7 members, the international community has come to recognize the need to address emerging and reemerging infectious diseases including efforts to combat AMR. The Sustainable Development Goals (SDGs), which were adopted in 2015 at the United Nations Sustainable Development Summit (UN Summit), provide a representative example of such efforts. SDG Target 3.3 reads, “End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases by 2030.” The SDGs have also adopted “Percentage of bloodstream infections due to selected antimicrobial-resistant organisms” as an indicator. In Japan, AMR was discussed as an independent item during the 2022 revision of the “Global Health Strategy,” which emphasized the need for AMR countermeasures. International society has come together to meet the SDGs by 2030 and AMR countermeasures must be positioned as a global priority topic alongside climate change and similar issues that require international collaboration and a One Health approach. Joint conferences such as those with Foreign Ministers and Health Ministers or Health Ministers and Finance Ministers should be held and AMR measures should be discussed.
The international collaboration needed for AMR control and its significanceAs we enter the post-COVID-19 era, we must not overlook the role of antimicrobials as global public goods if we wish to continue enjoying peace, stability, and prosperity. For example, Ukraine is currently faced with the issue of AMR in the form of an epidemic of multi-drug resistant tuberculosis (MDR-TB). As discussions on international agreements regarding infectious diseases like the International Health Regulation (IHR) and the Pandemic Treaty continue to advance, it will be important to promote AMR countermeasures based on the concept of One Health, in which the health of humans, animals, and the environment are viewed as one. To this end, opportunities for discussions that cut across fields and advocate for that approach should be established at G7 Summits and other high-level meetings. As the next G7 President in 2023, it will be crucial for Japan to fulfill its commitments to the international community based on the fact that infectious disease control cannot be fully implemented by countries acting alone and that each country’s interests are adjacent to those of the entire world.
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)